Jacobs C, Sari R
Blood Purif. 1986;4(1-3):32-9. doi: 10.1159/000169424.
The performances and clinical tolerance of a flat plate dialyzer equipped with a polycarbonate polyether copolymer membrane (surface area 1.13 and 0.80 m2, membrane thickness 16 micron) were evaluated in 10 patients, among whom 7 underwent a total of 523 dialysis sessions performed over a 6-month investigation period. Clinical and biological parameters recorded during the study were compared to those observed during an immediately preceding control period during which the same patients were dialyzed with flat plate or hollow fiber Cuprophan dialyzers. The clearances of the 1.13 m2 polycarbonate dialyzer for urea, creatinine, uric acid and inorganic phosphate determined at 36 +/- 14 min after start of the dialysis sessions were found respectively at 132 +/- 23, 103 +/- 22, 120 +/- 23 and 103 +/- 18 ml/min and at significantly higher values (except for uric acid) at the 4th hour of dialysis. The ultrafiltration rate was 490 ml/h for a 100 mm Hg transmembrane pressure and the residual blood volume at the end of dialysis was found at 1.1 +/- 0.3 ml. The main clinical and biological parameters recorded in the 7 patients treated for 6 months with polycarbonate dialyzers were not significantly different from those observed during the preceding control period, although 71% of the polycarbonate dialyzers had a smaller surface area than in those used during the control period. The overall blood leakage rate recorded in 555 polycarbonate dialyzers was 1.08%. No sign or symptom suggestive of clinical intolerance to the polycarbonate membrane was recorded during the entire course of the study.
对配备聚碳酸酯聚醚共聚物膜(表面积1.13和0.80平方米,膜厚度16微米)的平板透析器的性能和临床耐受性进行了评估,研究对象为10名患者,其中7名患者在6个月的研究期内共进行了523次透析治疗。将研究期间记录的临床和生物学参数与紧接在前的对照期内观察到的参数进行比较,在对照期内,相同的患者使用平板或中空纤维铜仿透析器进行透析。在透析开始36±14分钟时测定的1.13平方米聚碳酸酯透析器对尿素、肌酐、尿酸和无机磷酸盐的清除率分别为132±23、103±22、120±23和103±18毫升/分钟,在透析第4小时时(尿酸除外)明显更高。对于100毫米汞柱的跨膜压力,超滤率为490毫升/小时,透析结束时的残余血量为1.1±0.3毫升。用聚碳酸酯透析器治疗6个月的7名患者记录的主要临床和生物学参数与对照期观察到的参数无显著差异,尽管71%的聚碳酸酯透析器表面积小于对照期使用的透析器。在555个聚碳酸酯透析器中记录的总体血液渗漏率为1.08%。在整个研究过程中,未记录到提示对聚碳酸酯膜临床不耐受的体征或症状。